News on companies and Eli Lilly

GLP-1 pill shows success for diabetes, weight loss, Eli Lilly says

Read on: CBS

Stocks making the biggest moves midday: Eli Lilly, Alphabet, Hertz, UnitedHealth and more

Read on: CNBC News

Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients; shares jump 14%

Read on: CNBC News

Eli Lilly promises to make new weight loss pill in the U.S.

Read on: Quartz

Stocks making the biggest moves premarket: Hertz, UnitedHealth, Eli Lilly and more

Read on: CNBC News

Eli Lilly's new obesity pill lowers blood sugar and aids weight loss

Read on: Financial Times

New Eli Lilly trial suggests weight-loss pill is as strong as Ozempic

Read on: NBC News

Stock Movers: UnitedHealth, Eli Lilly, Netflix.com

Read on: Bloomberg

Daily GLP-1 pill effective for diabetes and obesity, Eli Lilly says

Read on: The Hill

Eli Lilly releases Zepbound obesity drug in Japan, targeting 'hidden' fat

Read on: Nikkei

Eli Lilly's weight loss pill could be just as good as Ozempic -- and the stock soars

Read on: Quartz

Eli Lilly releases obesity drug in Japan, targeting 'hidden' fat

Read on: Nikkei

Stocks making the biggest moves premarket: Walmart, Target, Apple, Pfizer, Eli Lilly, Ford and more

Read on: CNBC News

Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro

Read on: CNBC News

Here are Tuesday's biggest analyst calls: Apple, Nvidia, Tesla, Eli Lilly, Charles Schwab, Netflix & more

Read on: CNBC News

EU regulator declines approval for Eli Lilly's new Alzheimer's drug

Read on: Financial Times

Eli Lilly Drug Reduces Mysterious Lp(a) Particle Involved in Heart Attack Risk

Read on: The New York Times

Eli Lilly is coming after makers of copycat versions of Zepbound

Read on: Quartz

Eli Lilly and Novo Nordisk are tackling heart health next

Read on: Quartz

Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly

Read on: CNBC News

Eli Lilly's Alzheimer's drug is rejected by EU regulators over brain swelling risk, despite U.S. approval

Read on: Quartz

Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer

Read on: CNBC News

Eli Lilly's online health platform just expanded beyond weight loss to tackle Alzheimer's

Read on: Quartz